Sangamo therapeutics, inc. (SGMO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating Activities:
Net loss

-42,974

4,501

-27,361

-30,356

-42,203

-19,219

-12,843

-16,640

-20,187

-13,091

-12,354

-12,491

-16,632

-9,624

-18,965

-26,575

-16,494

-14,013

-9,245

-12,126

-5,319

-4,319

-7,545

-6,981

-7,572

-8,144

-6,145

-5,450

-6,885

-3,478

-5,790

-5,728

-7,268

-6,359

-9,554

-10,259

-9,578

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,311

1,158

1,159

868

715

732

461

619

588

470

412

317

301

252

252

248

245

243

317

281

147

149

150

127

123

124

140

158

147

160

166

166

168

167

160

157

162

Amortization of discount on marketable securities

744

993

1,260

1,217

1,238

1,786

2,387

1,197

459

363

342

28

-60

-62

-26

-61

-72

-146

-217

-223

-241

-255

-260

-288

-295

-287

-1,081

225

231

-1,581

202

218

272

339

451

466

320

Amortization and other changes in right-of-use assets

-1,886

-

-

-

-782

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on free shares

-73

-

-

-

545

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

5,620

5,239

4,701

4,867

4,523

4,303

3,810

3,514

3,050

2,120

2,218

1,963

2,788

1,929

2,735

7,199

3,194

3,066

2,828

2,883

2,953

3,035

2,129

2,129

1,907

2,048

1,391

1,378

1,329

1,327

1,404

1,224

1,383

2,099

2,053

1,966

1,963

Net loss on lease termination

0

0

0

0

-218

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-1,800

100

50

30

50

-

-

-

-

-

-

-

-

-

-

-

-

Intangible impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,870

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Benefit from income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,635

-3,339

0

-748

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Build-to-suit leases

-

-

-

-

-

-

-

-

-217

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

0

-

40

33

-44

-

-

-

-

-

-

-

-72

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net changes in operating assets and liabilities:
Interest receivable

244

2

-86

172

219

-308

121

189

133

-243

227

-142

174

-86

11

-103

95

-92

6

-5

-25

110

2

-72

45

130

-65

15

68

-121

112

-171

39

-211

33

117

55

Accounts receivable

-29,939

14,956

9,858

4,784

2,638

-895

591

1,402

232

-90

-62

1,094

-2,571

3,183

-823

-262

46

-4,483

1,825

-1,459

-3,730

1,894

1,505

1,609

2,205

-1,704

-93

1,335

-546

829

263

1,733

589

-234

-228

-89

1,104

Prepaid expenses and other assets

100

1,926

-715

6,601

-1,152

977

-1,713

2,230

1,334

-74

-296

1,109

-70

387

215

682

-172

-247

-260

232

-101

-801

-17

1,005

71

93

-366

814

-61

-378

96

328

-60

-251

-92

404

-48

Prepaid rent

0

-

-

-

12,101

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

345

-2,439

-3,564

-8,372

10,183

-7,161

-1,944

2,810

-77

-457

1,022

3,072

-418

-416

-687

3,926

-5,158

1,770

-2,983

2,926

-2,477

705

2,290

-403

1,732

1,892

-629

761

-1,480

2,267

-903

203

-3,070

3,049

-183

141

-3,146

Accrued compensation and employee benefits

-4,965

2,521

2,372

2,542

-3,306

1,477

2,260

1,135

-2,268

1,005

1,565

870

-846

48

635

480

-1,026

-31

759

317

-1,150

189

691

502

-1,723

1,155

596

309

-1,339

641

537

298

-676

315

355

136

-491

Deferred revenues

-8,319

-15,216

-9,656

-10,451

-370

-19,176

-19,934

135,773

2,701

-7,094

-8,268

65,216

-870

-1,127

-1,688

-1,175

-1,224

-3,472

-1,181

-3,761

34

-1,623

-2,303

-1,724

18,888

-560

-560

-510

-560

-684

-304

-504

12,626

-304

-37

354

-77

Long-term portion of lease liabilities

-887

-880

-357

-497

-66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

169

169

2,253

1,377

-50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-18,890

-20,816

-38,874

-39,593

-45,119

-40,161

-27,596

122,441

-18,134

-16,842

-15,687

56,786

-13,078

-11,768

-17,578

-16,177

-20,360

-9,104

-14,198

-8,025

-2,393

-2,712

-5,768

-8,574

11,379

-1,657

-4,514

-5,293

-8,018

223

-5,159

-6,013

2,867

2

-6,468

-7,471

-11,958

Investing Activities:
Purchases of marketable securities

43,580

122,321

77,084

157,231

87,075

0

-1

387,839

63,401

22,733

70,429

120,193

38,973

30,511

42,239

61,074

84,816

89,361

47,732

81,472

39,423

51,417

109,382

50,230

16,773

81,733

9,637

10,951

16,573

20,858

23,065

34,652

12,853

30,448

3,642

63,762

15,122

Maturities of marketable securities

71,075

112,700

65,263

148,631

78,253

161,298

97,250

78,847

54,450

51,582

44,064

37,529

45,500

37,000

74,410

57,317

68,770

134,686

69,940

74,280

58,955

51,160

26,001

29,818

20,786

12,745

10,964

14,510

12,910

28,315

23,035

34,300

17,820

25,538

13,318

22,118

22,438

Purchases of property and equipment

3,775

6,781

4,134

3,783

5,977

28,037

9,260

3,152

2,616

878

698

1,707

468

223

153

104

252

-

245

998

1,084

-

94

339

126

37

46

281

68

360

100

45

218

205

175

86

110

Net cash provided by (used in) investing activities

23,720

-16,402

-16,217

-12,383

-14,799

62,835

82,770

-312,144

-11,567

27,971

-27,063

-84,371

6,059

6,266

32,018

-3,861

-16,298

45,241

21,963

-8,190

18,448

-319

-83,475

-20,751

3,887

-68,946

1,281

3,278

-3,731

7,097

-130

-397

4,749

-5,115

19,640

-41,730

7,206

Proceeds from public offering of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

0

11

78,137

3,425

-

-

-

-

-

-

-

-

0

0

10

93,786

-

-

-

-

-

-

-

-

-

-

-

-

Taxes paid related to net share settlement of equity awards

411

12

92

31

265

217

26

43

14

-

-

3

4

-

-

532

2

1,498

0

41

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and restricted stock units

820

-2,846

796

3,613

481

-12,985

1,184

2,688

10,597

-2,796

2,789

802

23

353

57

516

187

556

1,302

1,768

3,178

2,412

1,178

1,762

7,585

-

-

-

-

635

537

396

108

-49,892

74

50,743

847

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,247

-

-

-

-

-

-

-

-

Net cash provided by financing activities

409

1,219

704

139,890

216

1,566

1,159

218,401

10,583

12,303

2,807

78,936

3,444

-423

591

-16

185

-942

15,754

1,727

3,171

-2,144

1,178

1,772

101,371

480

71,490

1,890

2,247

635

537

396

108

212

74

50,743

847

Effects of changes in foreign exchange rates

82

136

-544

340

252

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash, cash equivalents, and restricted cash

5,321

-35,863

-54,931

88,254

-59,450

24,679

56,333

28,698

-19,118

23,432

-39,943

51,351

-3,575

-5,925

15,031

-20,054

-36,473

35,195

23,519

-14,488

19,226

-5,175

-88,065

-27,553

116,637

-70,123

68,257

-125

-9,502

7,955

-4,752

-6,014

7,724

-4,901

13,246

1,542

-3,905

Supplemental disclosure of non-cash activities:
Right-of-use assets obtained in exchange for lease obligations

0

1,644

-24

22,995

6,676

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License included in accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

950

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and Equipment
Capital expenditures included in unpaid liabilities

1,080

-2,143

2,578

-155

1,834

-860

3,977

609

1,227

-

-

-

-

-

1,955

-6

253

-

-

-495

579

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-